Advertisement

Reactions Weekly

, Volume 1765, Issue 1, pp 262–262 | Cite as

Pembrolizumab

Febrile neutropenia: case report
Case report
  • 16 Downloads

Reference

  1. Naqash AR, et al. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition. Journal for ImmunoTherapy of Cancer 7: 169, No. 1, 5 Jul 2019. Available from: URL: http://doi.org/10.1186/s40425-019-0648-3 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations